Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021
March 09 2021 - 7:30AM
Liquidia Corporation (NASDAQ: LQDA) today announced that 2020
financial results will be reported on Tuesday, March 23, 2021. The
company will host a webcast and conference call at 8:30 a.m. ET to
discuss financial results and provide a corporate update.
The live call may be accessed by dialing 1-877-707-8711
(domestic) or 1-857-270-6219 (international) and entering the
conference code: 5167825. A live and archived webcast of the call
will be available on the Events & Presentations page of
Liquidia’s website.
About Liquidia CorporationLiquidia
Corporation is a biopharmaceutical company focused on the
development and commercialization of products in pulmonary
hypertension and other applications of its PRINT technology. The
Company operates through two subsidiaries, Liquidia Technologies,
Inc. and Liquidia PAH, LLC. Liquidia Technologies is developing two
product candidates: LIQ861, an inhaled dry powder formulation of
treprostinil for the treatment of pulmonary arterial hypertension
(PAH), and LIQ865, an injectable, sustained-release formulation of
bupivacaine for the management of local post-operative pain for
three to five days after a procedure. Liquidia PAH, LLC provides
commercialization for rare disease pharmaceutical products, such as
Treprostinil Injection, Sandoz Inc.’s first-to-file, generic
treprostinil for PAH.
Liquidia Corporation is headquartered in Research
Triangle Park, NC. For more information, please
visit www.liquidia.com.
Contact InformationMedia &
Investors:Jason AdairVice President, Corporate Development
and Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2023 to Apr 2024